ACADIA Pharmaceuticals, Inc.
(NASDAQ : ACAD)

( )
ACAD PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -6.73%146.810.0%$1534.10m
OCGNOcugen, Inc. -4.19%9.600.0%$1069.86m
NVAXNovavax, Inc. -14.27%205.9992.9%$909.19m
AMGNAmgen, Inc. -0.60%225.691.3%$548.32m
VRTXVertex Pharmaceuticals, Inc. 0.80%212.061.9%$521.91m
REGNRegeneron Pharmaceuticals, Inc. -1.77%454.862.7%$509.91m
ILMNIllumina, Inc. -1.23%441.013.5%$504.66m
GILDGilead Sciences, Inc. 0.88%63.011.0%$479.35m
ALXNAlexion Pharmaceuticals, Inc. -1.05%150.372.0%$354.39m
BNGOBionano Genomics, Inc. -3.66%9.480.0%$340.06m
BIIBBiogen, Inc. -1.24%269.851.7%$329.36m
CRSPCRISPR Therapeutics AG -0.37%129.770.6%$302.39m
EXASEXACT Sciences Corp. -2.72%136.3918.4%$253.67m
SGENSeagen Inc. 0.76%153.715.8%$214.53m
VXRTVaxart, Inc. -5.43%7.140.0%$189.51m

Company Profile

ACADIA Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the development and commercialization of medicines to address unmet medical needs in central nervous system, or CNS, disorders. The firms product include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. The company was founded by Mark R. Brann on July 16, 1993 and is headquartered in San Diego, CA.